Global Patent Index - EP 1071329 A4

EP 1071329 A4 20010502 - METHODS AND COMPOSITIONS FOR TREATMENT OF AIDS-ASSOCIATED KAPOSI'S SARCOMA

Title (en)

METHODS AND COMPOSITIONS FOR TREATMENT OF AIDS-ASSOCIATED KAPOSI'S SARCOMA

Title (de)

VERFAHREN UND ZUSAMMENSETZUNGEN FÜR DIE BEHANDLUNG VON AIDS-BEDINGTEM KARPOSI-SARKOM

Title (fr)

PROCEDES ET COMPOSITIONS PERMETTANT DE TRAITER LE SARCOME DE KARPOSI ASSOCIE AU SIDA

Publication

EP 1071329 A4 20010502 (EN)

Application

EP 98913281 A 19980330

Priority

US 9806221 W 19980330

Abstract (en)

[origin: WO9965307A1] The present invention comprises methods and compositions for treating a human with AIDS-associated Kaposi's sarcoma. More specifically, the method comprises administration of a taxane composition over a 3 hour infusion schedule. Importantly, the compositions and methods of administration allows for reduction of side effects and reduces the symptoms of Kaposi's sarcoma.

IPC 1-7

A01N 43/20; A61K 31/335; A61K 38/55; A61P 31/18

IPC 8 full level

A01N 43/20 (2006.01); A61K 31/337 (2006.01); A61K 31/70 (2006.01); A61K 45/00 (2006.01); A61K 45/06 (2006.01); A61P 35/00 (2006.01); A61P 37/04 (2006.01); A61P 43/00 (2006.01)

CPC (source: EP)

A61K 31/337 (2013.01); A61K 31/70 (2013.01); A61K 45/06 (2013.01); A61P 31/18 (2017.12); A61P 35/00 (2017.12); A61P 37/04 (2017.12); A61P 43/00 (2017.12)

Citation (search report)

  • [Y] BURDICK A E. ET AL: "Resolution of Kaposi s sarcoma associated with undetectable level of human Herpesvirus 8 DNA in a patient with AIDS after Protease Inhibitor Therapy", JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, vol. 37, no. 4, 1997, pages 648 - 649, XP000983556
  • [Y] CONANT M.A. ET AL: "Reduction of Kaposi s sarcoma lesions following treatment of AIDS with Ritonovir", AIDS, vol. 11, no. 10, - 1997, pages 1300 - 1301, XP000983605
  • [Y] VON ROENN J.: "Management of AIDS-associated Kaposi 's sarcoma: A multidisciplinary perspective.", ONCOLOGY, (1998) 12/2 SUPPL. 3 (9-24)., XP000983550
  • [Y] WELLES L. ET AL.: "Phase II Trial with dose titration of Paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi s sarcoma.", JOURNAL OF CLINICAL ONCOLOGY, vol. 16, no. 3, 1998 - March 1998 (1998-03-01), pages 1112 - 1121, XP000983694
  • See references of WO 9965307A1

Designated contracting state (EPC)

AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

DOCDB simple family (publication)

WO 9965307 A1 19991223; AU 6787398 A 20000105; CA 2301665 A1 19991223; CN 1255041 A 20000531; EP 1071329 A1 20010131; EP 1071329 A4 20010502; JP 2002518297 A 20020625

DOCDB simple family (application)

US 9806221 W 19980330; AU 6787398 A 19980330; CA 2301665 A 19980330; CN 98805000 A 19980330; EP 98913281 A 19980330; JP 2000554198 A 19980330